Emerging principles in neurocritical care: An analytical study of pharmaceuticals for mental health disorders

Abstract

In India, neurocritical care drugs are a promising choice for treating mental health conditions. Understanding the neurochemical imbalances that take place in diverse mental diseases forms the foundation for the concepts guiding the administration of these medications. One of the guiding concepts is the use of SSRIs (selective serotonin reuptake inhibitors) in the management of anxiety and depressive disorders. Serotonin availability in the brain is increased by SSRIs, which may decrease the symptoms of various diseases. Atypical antipsychotics being used to treat schizophrenia and other psychotic diseases is another crucial idea. The brain's dopamine receptors are blocked by these medications, which can lessen the severity of psychotic symptoms. Additionally, the use of mood stabilizers for the treatment of bipolar disorder is gaining popularity. These medications support the management of mood fluctuations and the avoidance of manic or depressive periods. The growing ideas in neurocritical care medicines for mental health disorders in India generally stress the significance of focusing on certain neurochemical imbalances to address mental illnesses.